BioCardia News - BCDA

Company Name	Stock Ticker Symbol	Market	Type
BioCardia Inc	BCDA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.368	07:00:08

Open Price	Low Price	High Price	Close Price	Prev Close
				0.368

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/25/2024	09:00	GLOBE	BioCardia Completes Enrollment of CardiAMP Cell Therapy for..
3/27/2024	16:00	GLOBE	BioCardia Reports Fourth Quarter and Full Year 2023 Business..
3/20/2024	07:00	GLOBE	BioCardia to Host 2023 Financial Results and Corporate..
3/13/2024	07:00	GLOBE	BioCardia and StemCardia Announce Biotherapeutic Delivery..
3/12/2024	07:00	GLOBE	BioCardia Announces CMS Approval of Coverage for CardiAMP..
3/04/2024	08:00	EDGAR2	Form 8-K - Current report
3/04/2024	08:00	GLOBE	BioCardia Reports Positive Interim Results from Phase III..
2/27/2024	16:53	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/15/2024	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	17:06	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:17	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2/09/2024	09:58	EDGAR2	Form 8-K - Current report
2/08/2024	07:03	EDGAR2	Form 8-K - Current report
2/08/2024	07:00	GLOBE	BioCardia Announces Activation of CardiAMP Heart Failure II..
2/06/2024	16:28	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/02/2024	14:06	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/31/2024	07:00	EDGAR2	Form 8-K - Current report
1/31/2024	07:00	GLOBE	BioCardia Announces Two Scientific Abstracts Have Been..
1/03/2024	07:00	EDGAR2	Form 8-K - Current report
1/03/2024	07:00	GLOBE	BioCardia Biotherapeutic Delivery and Morph Access..
12/19/2023	07:00	EDGAR2	Form 8-K - Current report
12/19/2023	07:00	GLOBE	BioCardia Doses First Patient in CardiALLO Phase I/II..
12/18/2023	07:16	GLOBE	BioCardia Announces Expected CardiAMP Heart Failure Japan..
12/18/2023	07:00	EDGAR2	Form 8-K - Current report
12/06/2023	06:05	EDGAR2	Form 8-K - Current report
12/06/2023	06:03	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/05/2023	16:11	EDGAR2	Form 8-K/A - Current report: [Amend]
12/05/2023	16:05	EDGAR2	Form 8-K - Current report
11/29/2023	07:00	EDGAR2	Form 8-K - Current report
11/29/2023	07:00	GLOBE	BioCardia Shares Update from Japan PMDA Consultation on..
11/17/2023	17:25	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/16/2023	17:15	EDGAR2	Form 8-K - Current report
11/16/2023	12:56	GLOBE	BioCardia Announces $1.3 Million Registered Direct Offering..
11/14/2023	07:15	GLOBE	BioCardia Announces FDA Approval of CardiAMP Heart Failure..
11/08/2023	16:11	GLOBE	BioCardia Reports Third Quarter 2023 Business Highlights and..
11/08/2023	16:08	EDGAR2	Form 8-K - Current report
11/08/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	17:04	GLOBE	BioCardia to Host Q3 2023 Corporate Update and Financial..
10/20/2023	09:26	EDGAR2	Form S-3 - Registration statement under Securities Act of..
10/19/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/19/2023	17:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/18/2023	16:30	EDGAR2	Form 8-K - Current report
10/11/2023	06:04	EDGAR2	Form 8-K - Current report
10/11/2023	06:00	GLOBE	BioCardia Announces Completion of Enrollment in Phase III..